i360medical appoints Jeremy Masding, former CEO of PTSB to board
blog template
0
min read

i360medical appoints Jeremy Masding, former CEO of PTSB to board

CEO Derek Young said the appointment underlined the ambition of i360medical as it moved into the next phase of its development.

i360medical, a leading Irish medical device innovation company has announced the appointment of Jeremy Masding, the former Group CEO of PTSB to its board.

Mr Masding, who was Group CEO from February 2012 to July 2020, is credited with leading the bank’s turnaround from an operating loss of c€1.5bn in 2011 to an operating profit of c€70m in 2019 and ultimately, securing its survival and re-IPO following the Irish banking crisis, state recapitalisation and negotiation of a restructuring plan with the European Commission.

Prior to PTSB, Mr Masding, who has over 30 years’ experience working in the financial sector, held a number of senior roles including at Barclays PLC.

Derek Young said the appointment underlined the ambition of i360medical as it moved into the next phase of its development.

“Jeremy brings a wealth of financial and management experience to the table and will be a tremendous asset to the company. Our vision has always been to engage a team of global experts to help us improve patient care and outcomes for patients by identifying innovative solutions and then ensuring they are brought to market as quickly as possible. We believe Jeremy will make a key contribution to our leadership team.”

Jeremy Masding said he was looking forward to helping i360medical deliver on its huge potential.

“i360’s unique business model has helped it become a global med-tech and innovation leader. Several projects are now moving towards fruition which is very positive both from a patient care perspective and in demonstrating the success of the company’s 7-step ideation process. It’s clear i360 is a business primed for scaling and I look forward to playing a full part in that profitable growth.”

Mr Masding’s appointment follows on from the recent election of leading US investor and med-tech innovator Bob Mitchell as interim Chair of the Board. Mitchell succeeds Ray Cantwell who served as chair for four years.

Mitchell who is currently serving as i360medical’s chief commercial officer and chair of the commercial advisory board, will continue to lead i360medical’s commercial efforts in those roles.

For further information
Contact Kieran Garry
GPR Communications
087/2368366

kierangarry@gprcomms.com